Results 101 to 110 of about 346 (139)

Navigating the challenges: a case report on managing a complicated postpartum course in type 3 von Willebrand disease with alloantibodies. [PDF]

open access: yesRes Pract Thromb Haemost
van der Zwet K   +5 more
europepmc   +1 more source

Radiosynovectomy in pigmented villonodular synovitis

Nuklearmedizin, 2000
Summary Background: Pigmented villonodular synovitis (PVS) is a very rare disorder characterized by a slowly progressive benign proliferation of synovial tissue. As yet, the mainstay of its treatment has been surgical or athroscopic synovectomy. However, the relapse rates reported are relatively high, ranging between 8% and 46%.
S, Kat   +4 more
openaire   +2 more sources

Radiosynovectomy is effective in thumb basal joint arthritis

Annals of Nuclear Medicine, 2021
Radiosynovectomy (RSO) describes the internal low-dose radiotherapy of the synovia via intra-articular administration of small radioactive particles. Since the introduction of biologics, the main aetiology of arthritic joints for RSO changed to mostly osteoarthritis with concordant change in typically affected joints.
Knut Liepe, Marcel Baehr
openaire   +2 more sources

Post-radiosynovectomy imaging utilizing Erbium-169 citrate

Applied Radiation and Isotopes, 2019
Currently, there is no imaging procedure for radionuclide therapy utilizing Erbium-169 (Er-169). We have recently published the first post-radiosynovectomy imaging of Er-169 citrate in a case report (Farahati et al., 2017). In this study, we performed in-vitro and in-vivo studies to evaluate the feasibility to assess the distribution of Er-169 citrate ...
Farahati, Jamshid   +12 more
openaire   +3 more sources

Radiosynovectomy in haemophilia

Blood Reviews, 2019
Radiosynovectomy (RS) is a simple, effective and safe procedure for the control of haemophilic synovitis that causes repetitive haemarthrosis. It must be done after confirming clinically (hard and painless mass on palpation) and by ultrasonography the existence of synovitis in a joint with recurrent haemarthrosis. RS should be the first invasive option
openaire   +2 more sources

Preparation of153Sm-particles for radiosynovectomy

Journal of Radioanalytical and Nuclear Chemistry, 1999
This paper summarizes the development and preparation procedures for two particulate preparations of153Sm, namely the hydroxyapatite (HA) particles and human serum albumin (HSA) microspheres. Preparation of153Sm-labeled hydroxyapatite particles and153Sm-labeled albumin microspheres were done in two steps.
M. G. Argüelles   +2 more
openaire   +1 more source

RADIATION PROTECTION IN RADIOSYNOVECTOMY OF THE KNEE

Health Physics, 2005
Radiosynovectomy is a widely available therapeutic option that involves radiopharmaceutical injections into joints to treat rheumatoid arthritis. However, data on the beta-radiation dose equivalents for the staff performing such treatments are limited.
Knut, Liepe   +3 more
openaire   +2 more sources

Radiosynovectomy

Blood Coagulation & Fibrinolysis, 2013
Haemophilic arthropathy occurs due to recurrent bleeding into joints leading to swelling, inflammation, destruction of cartilage and bone, and development of arthritis. Although prophylactic replacement therapy assists in preventing arthropathy, it is not always adequate or affordable. Radiosynovectomy is a minimally invasive intervention for treatment
Angeli G, Rampersad   +5 more
openaire   +2 more sources

90Y Radiosynovectomy in Persistent Synovitis Caused by Knee Replacement

Clinical Nuclear Medicine, 2021
Introduction After knee replacement, therapy resistant, persistent synovitis is a common issue, which causes effusion and pain, and leads to loosing. It has been hypothesized that radiosynovectomy (RSO) is useful in these patients.
Knut, Liepe, Marcel, Baehr
openaire   +2 more sources

Efficacy of radiosynovectomy in rheumatoid arthritis

Rheumatology International, 2011
In this retrospective study, we evaluated the effect of radiosynovectomy of patients with rheumatoid arthritis. Radiosynovectomy was performed in 577 joints of 137 rheumatoid patients. We applied 185 MBq yttrium-90 in knees (n = 58), 74-111 MBq rhenium-186 colloids in ankle (n = 50), wrists (n = 43) and shoulders (n = 35), and 15 to 37 MBq in finger (n
openaire   +2 more sources

Home - About - Disclaimer - Privacy